IOVS Human Reproduction
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anthony, T. L.
Right arrow Articles by Weinreb, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anthony, T. L.
Right arrow Articles by Weinreb, R. N.
(Investigative Ophthalmology and Visual Science. 2002;43:3705-3711.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Latanoprost’s Effects on TIMP-1 and TIMP-2 Expression in Human Ciliary Muscle Cells

Todd L. Anthony, James D. Lindsey and Robert N. Weinreb

From the Hamilton Glaucoma Center, University of California San Diego, La Jolla, California.

PURPOSE. To determine the effect of treatment with latanoprost on the tissue inhibitors of metalloproteinase (TIMP)-1 and -2 in cultured human ciliary muscle (HCM) cells.

METHODS. Confluent serum-starved HCM cells were exposed to increasing concentrations of latanoprost acid (LA, 1 nM to 10 µM) for 6, 18, and 24 hours. TIMP-1 and -2 mRNA transcripts were evaluated by RT-PCR. Gelatin zymography was used to measure changes in the amount of matrix metalloproteinase (MMP) in the culture medium. To evaluate the potential role of PKC, HCM cells were treated with phorbol 12-myrisate 13-acetate (PMA) in the absence or presence of the PKC inhibitor bisindolylmaleimide I (Bis I) or the PKA inhibitor KT5720. Data were quantitated by densitometry and statistically analyzed with the Student-Newman-Keuls test.

RESULTS. TIMP-1 and -2 mRNA transcripts and proteins were detected in primary cultures of HCM cells. TIMP-1 mRNA levels were unchanged at 6 hours, but increased 45% ± 17% and 54% ± 13% in cultures exposed for 18 hours to 1 and 10 µM LA, respectively (n = 3). In contrast, 6 hours of exposure to LA increased expression of TIMP-2 mRNA by up to 11.3% ± 0.2% (n = 3). However, no significant induction of TIMP-2 mRNA was observed at either 18 or 24 hours (n = 3). TIMP-1 protein was significantly increased in cultures exposed to LA for 18 and 24 hours. In contrast, TIMP-2 protein expression was insignificantly different from control cultures at 6, 18, and 24 hours of treatment. HCM cells exposed to PMA for 24 hours produced similar increases in TIMP-1 mRNA levels, as seen with latanoprost (n = 5). However, no significant induction of TIMP-2 mRNA was observed. Zymographic analysis of the media from these cultures confirmed dose-dependent increases of MMP-1 at 6, 18, and 24 hours, whereas dose-dependent increases in MMP-2 were seen only after 24 hours’ exposure to LA (n = 3). TIMP-1 protein levels were increased 27% ± 9.3% and 15% ± 11% in the media of cells exposed for 24 hours to 100 nM LA and 100 nM PMA, respectively (n = 5). The increases in TIMP-1 protein induced by LA were essentially eliminated by Bis I (n = 3) and unaffected by KT5720 (n = 3).

CONCLUSIONS. For the most part, TIMP-1, and not TIMP-2, contributes to regulation of MMP within the uveoscleral outflow pathway after exposure to latanoprost. Moreover, this induction appears to be meditated by activation of PKC.




This article has been cited by other articles:


Home page
IOVSHome page
C. Gutierrez-Ortiz, M. A. Teus, and G. Bolivar
Short-Term Effects of Latanoprost on Anterior Chamber Depth in Patients with Glaucoma or Ocular Hypertension
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4856 - 4859.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D.-J. Oh, J. L. Martin, A. J. Williams, R. E. Peck, C. Pokorny, P. Russell, D. E. Birk, and D. J. Rhee
Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 953 - 963.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S L Ho, G F Dogar, J Wang, J Crean, Q D Wu, N Oliver, S Weitz, A Murray, P E Cleary, and C O'Brien
Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome
Br. J. Ophthalmol., February 1, 2005; 89(2): 169 - 173.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. N. Weinreb, J. D. Lindsey, G. Marchenko, N. Marchenko, M. Angert, and A. Strongin
Prostaglandin FP Agonists Alter Metalloproteinase Gene Expression in Sclera
Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4368 - 4377.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology